Business Description
Ise Chemicals Corp
ISIN : JP3139300002
Total Employee Number:
339Description
Ise Chemicals Corp engages in the production and distribution of iodine, metallic compounds, and natural gas. The company offers iodine for use in X-ray contrast media, pesticides, liquid crystal display polarizers, and laser beams. It also produces cobalt and nickel compounds for use in capacitors and lithium-ion batteries; and produces and supplies natural gas to gas companies and factories. Geographically, the company operates in Japan, Asia, America and Europe.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 21.01 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.05 | |||||
Interest Coverage | 1889 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 15.04 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 27.4 | |||||
3-Year EPS without NRI Growth Rate | 36.2 | |||||
3-Year FCF Growth Rate | 383.3 | |||||
3-Year Book Growth Rate | 11.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.43 | |||||
Quick Ratio | 2.65 | |||||
Cash Ratio | 1.55 | |||||
Days Inventory | 153.83 | |||||
Days Sales Outstanding | 84.4 | |||||
Days Payable | 50.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.03 | |||||
Dividend Payout Ratio | 0.31 | |||||
3-Year Dividend Growth Rate | 28.2 | |||||
Forward Dividend Yield % | 1.04 | |||||
5-Year Yield-on-Cost % | 5.4 | |||||
Shareholder Yield % | 0.91 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.66 | |||||
Operating Margin % | 23.71 | |||||
Net Margin % | 16.22 | |||||
EBITDA Margin % | 28.07 | |||||
FCF Margin % | 11.79 | |||||
OCF Margin % | 18.3 | |||||
ROE % | 16.77 | |||||
ROA % | 13.44 | |||||
ROIC % | 20.62 | |||||
3-Year ROIIC % | 50 | |||||
ROC (Joel Greenblatt) % | 30.76 | |||||
ROCE % | 22.76 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 34.58 | |||||
Forward PE Ratio | 3.84 | |||||
PE Ratio without NRI | 34.23 | |||||
Shiller PE Ratio | 89.28 | |||||
PEG Ratio | 1.18 | |||||
PS Ratio | 5.61 | |||||
PB Ratio | 5.53 | |||||
Price-to-Tangible-Book | 5.67 | |||||
Price-to-Free-Cash-Flow | 46.08 | |||||
Price-to-Operating-Cash-Flow | 29.68 | |||||
EV-to-EBIT | 23.37 | |||||
EV-to-EBITDA | 19.09 | |||||
EV-to-Revenue | 5.36 | |||||
EV-to-FCF | 44.02 | |||||
Price-to-GF-Value | 1.76 | |||||
Price-to-Projected-FCF | 4.48 | |||||
Price-to-Median-PS-Value | 5.38 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.36 | |||||
Price-to-Graham-Number | 2.94 | |||||
| Price-to-Net-Current-Asset-Value | 10.35 | |||||
| Price-to-Net-Cash | 112.41 | |||||
Earnings Yield (Greenblatt) % | 4.28 | |||||
FCF Yield % | 2.17 | |||||
Forward Rate of Return (Yacktman) % | 20.58 |
Ise Chemicals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ise Chemicals Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| JPY 20.000000 Cash Dividend | 2026-06-29 | -- | ||
| JPY 20.000000 Cash Dividend | 2025-12-29 | 3.28 (+0.00%) | ||
| 10:1 Stock Split | 2025-12-29 | 3.28 (+0.00%) | ||
| JPY 19.000000 Cash Dividend | 2025-06-27 | 3.28 (+0.00%) | ||
| JPY 20.000000 Cash Dividend | 2024-12-27 | 3.28 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:ICHMF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ise Chemicals Corp
No articles.